SUBSCRIBE
SUBSCRIBE

Biogen

NEWS
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Biotech Beach
Why Amgen, Biogen and Celgene are the Best Biotech Stocks Now
October 11, 2016
 · 
2 min read
Genetown
Celgene Could Dethrone Biogen in Multiple Sclerosis
September 29, 2016
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
This Little Biotech Could be a New Acquisition Target for Allergan and Biogen
September 21, 2016
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Drug Development
Will Biogen’s Alzheimer’s Drug Be a Miracle Drug or Just Another Bomb?
September 20, 2016
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Business
Advice for Biogen: Take a Page Out of Biotech’s Best Friend Celgene’s Playbook
September 9, 2016
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Deals
Is Biogen Even Buyout Worthy?
September 6, 2016
 · 
3 min read
Deal Spree Continues as Allergan Inks $2.47 Billion Deal for This Bay Area Biotech
Deals
Allergan’s Brent Saunders Denies Interest in Biogen or Big M&A
August 10, 2016
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Business
Biogen Unveils Name for New Standalone Hemophilia-Focused Company: Bioverativ
August 9, 2016
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Deals
Biogen Not Pursuing an Acquisition, Says Source
August 4, 2016
 · 
3 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Business
Biogen Idec, Inc. (Massachusetts), Isis Pharmaceuticals, Inc. Form Up to $271 Million Pact for Drug to Treat Steinart Disease
June 29, 2012
 · 
9 min read
Business
Sunesis Pharmaceuticals, Inc. Receives $1.5 Million Milestone Payment from Biogen Idec, Inc. (Massachusetts) Related to Kinase Inhibitor Program
June 27, 2012
 · 
2 min read
Business
Drugmakers Including Abbott Laboratories, Biogen Idec, Inc. (Massachusetts) and Merck & Co., Inc. Form Consortium
June 20, 2012
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) to Highlight Innovative Pipeline and Commercial Strategy
June 12, 2012
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) Announces Webcast of 2012 Analyst Day
June 6, 2012
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) 2012 Annual Shareholders Meeting Webcast
June 1, 2012
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) Continues Support for MS Community With Worldwide Celebrations on Fourth Annual World MS Day
May 30, 2012
 · 
1 min read
Genetown
Boston CEO Conference to Feature CEOs of Alkermes plc, Alnylam Pharmaceuticals, Ariad Pharmaceuticals, Inc., Biogen Idec, Inc. (Massachusetts), Cubist Pharmaceuticals, Inc., Genzyme Corporation, Millennium, Momenta Pharmaceuticals, Inc., Sirtris Pharmaceu
May 24, 2012
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts)'s New AVONEX® Dosing Innovations for People with Multiple Sclerosis Now Available in US
May 14, 2012
 · 
1 min read
Policy
Biogen Idec, Inc. (Massachusetts) Release: US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review
May 10, 2012
 · 
1 min read
Load More